Head-to-Head Comparison Summary
Mitochondrial bioenergetics ✅ Primary: AMPK-PGC-1α-OCR ❌ Minimal/indirect MOTS-C dominant Metabolic syndrome of ageing ✅ HOMA-IR −41%; visceral fat −28–34% ⚡ Modest: −12–16% via cortisol Stress-induced senescence (SIPS) ✅ β-gal 62→28%; AMPK-FOXO3a-MnSOD ❌ Not
This comparison does not assign a generated winner or score.
- Mitochondrial bioenergetics
- ✅ Primary: AMPK-PGC-1α-OCR
- ❌ Minimal/indirect
- MOTS-C dominant
- Metabolic syndrome of ageing
- ✅ HOMA-IR −41%; visceral fat −28–34%
- ⚡ Modest: −12–16% via cortisol
- Stress-induced senescence (SIPS)
- ✅ β-gal 62→28%; AMPK-FOXO3a-MnSOD
- ❌ Not characterised
- Replicative senescence (telomere)
- ⚡ Partial: 78→58% β-gal
- ✅ Primary: TERT↑ telomere +0.6kb; 78→48% β-gal
- 78→34% (additive)
- Circadian/melatonin
- ❌ No activity
- ✅ Primary: melatonin +71%; BMAL1 42→74%
- Epitalon dominant
- Glymphatic Aβ clearance
- ❌ No significant effect
- ✅ 42→58% clearance; luzindole block
- Adaptive immune senescence
- ⚡ MOTS-C indirect (metabolic rescue)
- ✅ Naive CD4+ 28→38%; TEMRA 22→14%
- Additive via different pathways
- Innate immune metabolic function
- ✅ Macrophage OCR +57%; phagocytic index +57%
- ⚡ Indirect via melatonin-cortisol
- Telomere length
- ✅ +0.4–0.8 kb; TERT mRNA +1.4–1.8×
- 🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified MOTS-C and Epitalon for research and laboratory use. View UK stock →
- William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.